-
1
-
-
84856679198
-
Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients
-
Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, Widmann WD: Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 2012, 19: 217-224.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 217-224
-
-
Azab, B.1
Bhatt, V.R.2
Phookan, J.3
Murukutla, S.4
Kohn, N.5
Terjanian, T.6
Widmann, W.D.7
-
2
-
-
84876985193
-
Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?
-
Cetin B, Berk V, Kaplan MA, Afsar B, Tufan G, Ozkan M, Isikdogan A, Benekli M, Coskun U, Buyukberber S: Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?Clin Genitourin Cancer 2013, 11: 141-148.
-
(2013)
Clin Genitourin Cancer
, vol.11
, pp. 141-148
-
-
Cetin, B.1
Berk, V.2
Kaplan, M.A.3
Afsar, B.4
Tufan, G.5
Ozkan, M.6
Isikdogan, A.7
Benekli, M.8
Coskun, U.9
Buyukberber, S.10
-
3
-
-
79954430604
-
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
-
Chua W, Charles KA, Baracos VE, Clarke SJ: Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 2011, 104: 1288-1295.
-
(2011)
Br J Cancer
, vol.104
, pp. 1288-1295
-
-
Chua, W.1
Charles, K.A.2
Baracos, V.E.3
Clarke, S.J.4
-
4
-
-
4143050218
-
The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8
-
De Larco JE, Wuertz BR, Furcht LT: The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 2004, 10: 4895-4900.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 4895-4900
-
-
de Larco, J.E.1
Wuertz, B.R.2
Furcht, L.T.3
-
5
-
-
77954818058
-
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM
-
Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010, 17: 1471-1474.
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 1471-1474
-
-
Edge, S.B.1
Compton, C.C.2
-
6
-
-
57849117384
-
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
-
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1. 1). Eur J Cancer 2009, 45: 228-247.
-
(2009)
Eur J Cancer
, vol.45
, pp. 228-247
-
-
Eisenhauer, E.A.1
Therasse, P.2
Bogaerts, J.3
Schwartz, L.H.4
Sargent, D.5
Ford, R.6
Dancey, J.7
Arbuck, S.8
Gwyther, S.9
Mooney, M.10
Rubinstein, L.11
Shankar, L.12
Dodd, L.13
Kaplan, R.14
Lacombe, D.15
Verweij, J.16
-
7
-
-
0020376310
-
Prognostic significance of morphologic parameters in renal cell carcinoma
-
Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6: 655-663.
-
(1982)
Am J Surg Pathol
, vol.6
, pp. 655-663
-
-
Fuhrman, S.A.1
Lasky, L.C.2
Limas, C.3
-
8
-
-
0036023415
-
Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance
-
Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL: Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 2002, 8: 2553-2562.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2553-2562
-
-
Hoffmann, T.K.1
Dworacki, G.2
Tsukihiro, T.3
Meidenbauer, N.4
Gooding, W.5
Johnson, J.T.6
Whiteside, T.L.7
-
9
-
-
78650389810
-
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy
-
Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, Clarke SJ: High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 2010, 16: 5805-5813.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 5805-5813
-
-
Kao, S.C.1
Pavlakis, N.2
Harvie, R.3
Vardy, J.L.4
Boyer, M.J.5
van Zandwijk, N.6
Clarke, S.J.7
-
10
-
-
84655160810
-
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
-
Keizman D, Ish-Shalom M, Huang P, Eisenberger MA, Pili R, Hammers H, Carducci MA: The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer 2012, 48: 202-208.
-
(2012)
Eur J Cancer
, vol.48
, pp. 202-208
-
-
Keizman, D.1
Ish-Shalom, M.2
Huang, P.3
Eisenberger, M.A.4
Pili, R.5
Hammers, H.6
Carducci, M.A.7
-
11
-
-
84856476390
-
Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems
-
Lamb GW, Aitchison M, Ramsey S, Housley SL, McMillan DC: Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems. Br J Cancer 2012, 106: 279-283.
-
(2012)
Br J Cancer
, vol.106
, pp. 279-283
-
-
Lamb, G.W.1
Aitchison, M.2
Ramsey, S.3
Housley, S.L.4
McMillan, D.C.5
-
12
-
-
47949096781
-
Cancer-related inflammation
-
Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature 2008, 454: 436-444.
-
(2008)
Nature
, vol.454
, pp. 436-444
-
-
Mantovani, A.1
Allavena, P.2
Sica, A.3
Balkwill, F.4
-
13
-
-
49549097136
-
An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
-
McMillan DC: An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 2008, 67: 257-262.
-
(2008)
Proc Nutr Soc
, vol.67
, pp. 257-262
-
-
McMillan, D.C.1
-
14
-
-
33846181370
-
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
-
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007, 356: 115-124.
-
(2007)
N Engl J Med
, vol.356
, pp. 115-124
-
-
Motzer, R.J.1
Hutson, T.E.2
Tomczak, P.3
Michaelson, M.D.4
Bukowski, R.M.5
Rixe, O.6
Oudard, S.7
Negrier, S.8
Szczylik, C.9
Kim, S.T.10
Chen, I.11
Bycott, P.W.12
Baum, C.M.13
Figlin, R.A.14
-
15
-
-
77956646156
-
Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma
-
Ohno Y, Nakashima J, Ohori M, Hatano T, Tachibana M: Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol 2010, 184: 873-878.
-
(2010)
J Urol
, vol.184
, pp. 873-878
-
-
Ohno, Y.1
Nakashima, J.2
Ohori, M.3
Hatano, T.4
Tachibana, M.5
-
16
-
-
84855576660
-
Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma
-
Ohno Y, Nakashima J, Ohori M, Gondo T, Hatano T, Tachibana M: Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma. J Urol 2012, 187: 411-417.
-
(2012)
J Urol
, vol.187
, pp. 411-417
-
-
Ohno, Y.1
Nakashima, J.2
Ohori, M.3
Gondo, T.4
Hatano, T.5
Tachibana, M.6
-
17
-
-
33846248715
-
Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer
-
Ramsey S, Lamb GW, Aitchison M, Graham J, McMillan DC: Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer 2007, 109: 205-212.
-
(2007)
Cancer
, vol.109
, pp. 205-212
-
-
Ramsey, S.1
Lamb, G.W.2
Aitchison, M.3
Graham, J.4
McMillan, D.C.5
-
18
-
-
78649637959
-
Role of C-reactive protein as a biomarker for renal cell carcinoma
-
Saito K, Kihara K: Role of C-reactive protein as a biomarker for renal cell carcinoma. Expert Rev Anticancer Ther 2010, 10: 1979-1989.
-
(2010)
Expert Rev Anticancer Ther
, vol.10
, pp. 1979-1989
-
-
Saito, K.1
Kihara, K.2
-
19
-
-
84865826931
-
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients
-
Steffens S, Köhler A, Rudolph R, Eggers H, Seidel C, Janssen M, Wegener G, Schrader M, Kuczyk MA, Schrader AJ: Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer 2012, 12: 399.
-
(2012)
BMC Cancer
, vol.12
, pp. 399
-
-
Steffens, S.1
Köhler, A.2
Rudolph, R.3
Eggers, H.4
Seidel, C.5
Janssen, M.6
Wegener, G.7
Schrader, M.8
Kuczyk, M.A.9
Schrader, A.J.10
-
20
-
-
3543102542
-
Inflammation and necrosis promote tumour growth
-
Vakkila J, Lotze MT: Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004, 4: 641-648.
-
(2004)
Nat Rev Immunol
, vol.4
, pp. 641-648
-
-
Vakkila, J.1
Lotze, M.T.2
-
21
-
-
85027920085
-
Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis
-
Wu Y, Fu X, Zhu X, He X, Zou C, Han Y, Xu M, Huang C, Lu X, Zhao Y: Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis. J Cancer Res Clin Oncol 2011, 137: 887-896.
-
(2011)
J Cancer Res Clin Oncol
, vol.137
, pp. 887-896
-
-
Wu, Y.1
Fu, X.2
Zhu, X.3
He, X.4
Zou, C.5
Han, Y.6
Xu, M.7
Huang, C.8
Lu, X.9
Zhao, Y.10
-
22
-
-
84886096714
-
Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
-
doi:10.1007/s10147-012-0454-0
-
Yasuda Y, Saito K, Yuasa T, Kitsukawa S, Urakami S, Yamamoto S, Yonese J, Takahashi S, Fukui I: Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Int J Clin Oncol 2012. doi: 10. 1007/s10147-012-0454-0.
-
(2012)
Int J Clin Oncol
-
-
Yasuda, Y.1
Saito, K.2
Yuasa, T.3
Kitsukawa, S.4
Urakami, S.5
Yamamoto, S.6
Yonese, J.7
Takahashi, S.8
Fukui, I.9
|